Health · 4 views
Subtype-specific mutations drive relapse risk in most common childhood leukemia
Some cases of the most common childhood cancer, B-cell acute lymphoblastic leukemia (B-ALL), return after treatment—and genetic changes present from the start may help explain why. Scientists at St.
Summary
Some cases of the most common childhood cancer, B-cell acute lymphoblastic leukemia (B-ALL), return after treatment—and genetic changes present from the start may help explain why. Scientists at St. Jude Children's Research Hospital and Seattle Children's Hospital, in collaboration with the Children's Oncology Group, found that mutations in a patient's original tumor can be associated with relapse risk, and that these changes differ by leukemia subtype. The findings, published in Blood , could help researchers better estimate and adjust for relapse risk before treatment begins.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Study challenges assumption that more lean body mass means better metabolic healthContinue reading
- Newcastle hospital told woman whose unborn baby had died to go home and ‘book a slot to give birth’Continue reading
- CT Images Facilitate PCI's 'New Era': Planning Before CatheterizationContinue reading
- Rising Health Costs, Coverage Changes Worry Older Adults as Election Day NearsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow